Waters and DAISO have jointly announced that they are entering into a collaborative agreement to globally market and supply DAISOGEL bulk packing materials for process chromatography.
Waters and DAISO have jointly announced that they are entering into a collaborative agreement to globally market and supply DAISOGEL bulk packing materials for process chromatography.
According to a statement from the companies, the combined purification expertise of both organizations will aid pharmaceutical and biopharmaceutical companies as they move from lab-scale purifications into pilot plant and process-scale manufacturing.
To simplify scaling-up purification methods, DAISOGEL columns are packed using Waters patented Optimum Bed Density (OBD) technology. Waters claims OBD technology enables analytical column performance and longer lifetimes in larger preparative columns.
DAISO’s quality control system is reported to be based on ISO 9001 and has met the quality requirements of global pharmaceutical companies. DAISO also has a DMF (Drug Master File) with the US Food and Drug Administration for the DAISOGEL packing materials.
For more information go to www.waters.com/purification and www.daiso-co.com/eng
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.